Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
AIDS and Behavior|April 1, 2022
HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South AfricaKristen M Little, Lola Flomen, Homaira Hanif, et al.
Frontiers in Reproductive Health|August 27, 2025
Inflammatory mediators and the RAGE pathway in placental tissues of pregnancies complicated by severe preeclampsiaNeelima Chandra, Thomas D Kimble, Kathleen R Heim, et al.
Pharmaceutics|August 4, 2019
Topical Inserts: A Versatile Delivery Form for HIV PreventionM Melissa Peet, Vivek Agrahari, Sharon M Anderson, et al.
Sexually Transmitted Diseases|July 9, 2008
The influence of depression on sexual risk reduction and STD infection in a controlled, randomized intervention trialAlan E C Holden, Rochelle N Shain, Warren B Miller, et al.
American Journal of Obstetrics and Gynecology|September 24, 2021
Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosisAndrew T Gustin, Andrea R Thurman, Neelima Chandra, et al.
The Journal of Sexual Medicine|July 30, 2024
Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorderAndrea R Thurman, Isabella Johnson, Katherine A Cornell, et al.
Frontiers in Cellular and Infection Microbiology|March 30, 2022
Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal RingAndrea R Thurman, Jacques Ravel, Pawel Gajer, et al.
Clinical and Translational Medicine|November 8, 2018
Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studiesTerry A Jacot, Meredith R Clark, Oluwatosin E Adedipe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate UsersAndrea R Thurman, Jill L Schwartz, Vivian Brache, et al.
Frontiers in Cellular and Infection Microbiology|May 8, 2023
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravirAndrea R Thurman, Louise A Ouattara, Nazita Yousefieh, et al.
Pageof 4